Somewhat Positive Press Coverage Somewhat Unlikely to Affect Proto Labs (PRLB) Share Price

News coverage about Proto Labs (NYSE:PRLB) has been trending somewhat positive on Monday, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Proto Labs earned a news impact score of 0.18 on Accern’s scale. Accern also assigned news coverage about the industrial products company an impact score of 46.7307414548866 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Here are some of the media stories that may have effected Accern Sentiment’s analysis:

PRLB has been the subject of a number of research reports. Dougherty & Co raised shares of Proto Labs from a “sell” rating to a “neutral” rating in a research report on Tuesday, June 27th. Zacks Investment Research cut shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 28th. Finally, Piper Jaffray Companies reissued a “hold” rating and issued a $67.00 price target on shares of Proto Labs in a research report on Friday, July 28th. Four analysts have rated the stock with a hold rating, Proto Labs currently has an average rating of “Hold” and an average target price of $59.33.

Proto Labs (PRLB) opened at 73.15 on Monday. The firm has a 50-day moving average of $72.06 and a 200-day moving average of $62.50. The firm has a market capitalization of $1.95 billion, a price-to-earnings ratio of 42.53 and a beta of 0.99. Proto Labs has a 1-year low of $43.10 and a 1-year high of $75.55.

Proto Labs (NYSE:PRLB) last posted its quarterly earnings data on Thursday, July 27th. The industrial products company reported $0.49 EPS for the quarter, beating the Zacks’ consensus estimate of $0.43 by $0.06. Proto Labs had a net margin of 14.59% and a return on equity of 11.75%. The firm had revenue of $82.04 million for the quarter, compared to the consensus estimate of $80.49 million. During the same period in the prior year, the firm posted $0.45 EPS. The firm’s revenue was up 9.4% compared to the same quarter last year. On average, analysts expect that Proto Labs will post $2.06 earnings per share for the current year.

In other Proto Labs news, VP Robert Bodor sold 741 shares of the stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $73.84, for a total transaction of $54,715.44. Following the transaction, the vice president now directly owns 17,319 shares in the company, valued at approximately $1,278,834.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 7.78% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://sportsperspectives.com/2017/09/11/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-proto-labs-prlb-share-price.html.

About Proto Labs

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Insider Buying and Selling by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply